abstract |
A compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein m, n, R 1 , R 2 , R 3 , R 4 and R 5 are as defined herein. Also disclosed are methods of making and using the compounds for the treatment of diseases associated with P2X 7 purinergic receptors. |